The company aims to conduct research and development of pharmaceutical and biotechnological products for human and/or veterinary use. This includes, in particular, the discovery, preclinical and clinical development of novel therapeutic agents and formulations. The company may establish branches and subsidiaries in Switzerland and abroad and may participate in other companies in Switzerland and abroad as well as conduct all business that is directly or indirectly related to its purpose. The company may acquire, encumber, dispose of and manage real estate in Switzerland and abroad. It may also arrange financing for its own or third-party account as well as provide guarantees and sureties for subsidiaries and third parties.